AI spots liver trouble hidden in heart scans
NCT ID NCT07216859
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study tests whether an artificial intelligence (AI) program can analyze routine heart ultrasound images to find people who may have undiagnosed fatty liver disease or cirrhosis. About 2,000 adults will have their heart scans checked by the AI. If the AI flags them as high risk, their doctors will be notified to consider follow-up tests. The goal is to see if this approach leads to faster diagnosis and treatment of liver disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90034, United States
-
Kaiser Permanente
Pleasanton, California, 94588, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Northwestern Medicine
Chicago, Illinois, 60611, United States
-
Stanford Healthcare
Palo Alto, California, 94588, United States
-
UCLA
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Could a common b vitamin tame fatty liver?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test